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Abstract
Introduction
Increased knowledge of breast cancer risk factors may enable a paradigm shift from one-
size-fits-all breast cancer screening to screening and subsequent prevention guided by a
woman’s individual risk of breast cancer. Professionals will play a key role in informing
women about this new personalised screening and prevention programme. Therefore, it is
essential to explore professionals’ views of the acceptability of this new programme, since
this may affect shared decision-making.
Methods
Professionals from three European countries (the Netherlands, United Kingdom, and Swe-
den) participated in digital concept mapping, a systematic mixed methods approach used to
explore complex multidimensional constructs.
Results
Across the three countries, professionals prioritised the following five themes which may
impact decision-making from the perspective of eligible women: (1) Anxiety/worry; (2) Pro-
active approach; (3) Reassurance; (4) Lack of knowledge; and (5) Organisation of risk
assessment and feedback. Furthermore, Dutch and British professionals expressed con-
cerns regarding the acceptability of a heterogeneous screening policy, suggesting women
will question their risk feedback and assigned pathway of care. Swedish professionals
emphasised the potential impact of the programme on family relations.
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Conclusions
The perspectives of Dutch, British, and Swedish professionals of women’s decision-making
regarding personalised breast cancer screening and prevention generally appear in line with
women’s own views of acceptability as previously reported. This will facilitate shared deci-
sion-making. However, concerns regarding potential consequences of this new programme
for screening outcomes and organisation need to be addressed, since this may affect how
professionals communicate the programme to eligible women.
Introduction
The current one-size-fits-all breast cancer screening strategy is effective in reducing breast can-
cer mortality, however increased knowledge of breast cancer risk factors may enable a more
personalised approach [1,2]. Defining screening regimens based on breast cancer risk is
expected to optimise the balance between the known benefits and harms of screening [3].
Risk-stratified screening delivery enables the determination of a more favourable screening
interval, age range, and screening modality for women at varying levels of breast cancer risk.
Furthermore, the existing screening infrastructure provides a valuable opportunity to educate
women on ways to actively reduce their risk, ultimately aiming to prevent breast cancer [4].
These promising prospects have led to the initiation of several large prospective studies devel-
oping breast cancer risk prediction models to guide screening and prevention on a population
level. However, successful implementation of risk-based breast cancer screening and preven-
tion is contingent on the acceptability of the programme, both from the perspective of eligible
women and professionals.
Although integrated risk-based screening and prevention is not yet practised, several stud-
ies have piloted breast cancer risk and prevention counselling in primary care settings. This
has led to the identification of considerable practical implications, e.g. time constraints and a
great need for additional [5–8]. Primary care professionals consistently reported a lack of
knowledge of all aspects of personalised screening and prevention [9–11]. Previous experience
with the prescription of preventative measures and having women show interest by initiating
the conversation about breast cancer risk facilitated acceptance, emphasising a shared deci-
sion-making process [9–11].
Healthcare professionals will play a key role in informing women about personalised breast
cancer screening and prevention. Although it has not yet been decided which healthcare pro-
fessionals will be involved in risk-based screening and prevention, it is conceivable that, for
example, radiologists, radiographers, oncologists, and GPs will encounter women with ques-
tions about participation. Their communication about the programme will be affected by
whether they perceive it to be acceptable, both in light of their personal day-to-day work activi-
ties and considering eligible women who may participate in the programme. It is important
that professionals prioritise women’s needs, since it is women who are likely to benefit from a
personalised screening and prevention approach. Women have previously spoken about
requiring additional knowledge about breast cancer risk to be able to decide on participating
in the programme [12]. They have also emphasised that they need a knowledgeable profes-
sional to inform them about their risk [13]. In general, women welcome breast cancer risk
communication as they feel it allows for a more proactive approach to breast cancer prevention
[14,15]. However, they have expressed concerns about subsequent anxiety and the potential
for stigma [16,17].
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To explore whether professionals’ views are in line with those of women, we have asked
professionals to consider risk-based breast cancer screening and prevention from the perspec-
tive of eligible women to evaluate acceptability. This will provide insights into professionals’
underlying beliefs and concerns regarding the programme. Professionals from three of the
countries that are currently developing a breast cancer risk prediction model participated, i.e.
the Netherlands, the United Kingdom, and Sweden. The resulting overview of perceptions will
be a valuable support tool to address the topic of personalised breast cancer screening and pre-
vention with professionals, health policy makers, and eligible women, taking into account
potential cultural variation across the three countries.
Methods
Study design
Professionals participated in digital concept mapping. We opted for concept mapping, because
it offers a systematic, time efficient way for our international healthcare professionals to
explore complex multidimensional constructs using a mixed-methods approach [18]. Ethics
approval was acquired from the regional ethics committee CMO Arnhem-Nijmegen in the
Netherlands, Health Research Authority in the United Kingdom, and the Regional Ethical
Review Board at the Karolinska Institutet Stockholm in Sweden. All participants provided
informed consent before the start of the study.
Participants
In total, 162 professionals were invited to participate in the study: 28 professionals in the Neth-
erlands, 59 in the UK, and 75 in Sweden. Convenience sampling was used to invite participants
who were part of the professional network of some of the researchers (MB, GE, YW, AJ). Invi-
tations were sent until at least ten professionals per country participated. Participants were
invited based on their extensive knowledge of breast cancer screening and/or prevention, and
their varied professional backgrounds and practice settings (i.e. screening, primary care, hospi-
tal). Participants were not necessarily aware of risk-based screening and prevention prior to
participation in the study. This enabled them to explore the concept without preconceived
ideas, which allowed for more diversity in participants’ perspectives. All participants were
practising their profession at the time of the study.
Procedure
Concept mapping includes seven structured steps: (1) define participants; (2) formulate the
seeding statement; (3) brainstorm: generate statements; (4) sort statements; (5) rate statements;
(6) analyse statements; and (7) interpret concept maps [18]. Steps 3 to 6 were performed digi-
tally using concept mapping software (Concept Systems Incorporated). The participants per-
formed steps 3 to 5, whereas steps 1, 2, 6, and 7 were performed by the researchers.
Participants were informed of each step by email, which also contained a link to the concept
mapping website and personal log-in details.
To obtain a broad range of perspectives, we asked each participant in all three countries to
individually brainstorm for ten minutes using a general seeding statement: ‘thinking as
broadly as you can, generate statements on perceptions (e.g. barriers/worries/fears/advan-
tages/facilitators) that women can have of personalised risk-based breast cancer screening and
primary prevention’. Participants in the Netherlands were provided with the seeding statement
in Dutch, all other participants were asked to perform the task in English. The statements of all
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participants were collected and sorted per country by the researchers. Duplicate statements
were removed.
Next, we presented each participant with all unique verbatim statements generated by all
other participants of their respective country, e.g. each Swedish participant was presented with
the statements generated by all other Swedish participants. Participants were then asked to
sort these statements according to theme, based on their personal judgement, and label each
category. There was no limit to the number of categories that could be generated.
Finally, each participant was asked to rate the statements generated by all participants of
their respective country on a scale from 1 to 10, using the following question: ‘take the perspec-
tive of a woman eligible for the national breast cancer screening programme, how important is
this statement for a woman’s consideration to participate or not participate in a personalised
risk-based breast cancer screening and prevention programme?’.
Additionally, participants provided information on some personal characteristics (i.e. age,
gender, profession, and years of work experience). Participant data was included for analysis if
at least 105 statements were categorised and at least one statement was rated, based on the
requirement settings of the concept mapping software.
Data analysis and interpretation
The concept mapping software uses multidimensional scaling and cluster analysis to identify
patterns in participants’ sorted and rated data, which are graphically represented by two-
dimensional cluster rating concept maps. The overall fit of the concept map is described by a
stress-value, which compares the obtained concept map to the dissimilarity matrix that served
as input [19]. A stress-value between 0.21 and 0.37 represents sufficient fit, where a lower value
within said interval is considered most optimal [19].
A cluster rating map was created for each country displaying clusters with statements similar
in thematic content. Additionally, the software calculated the average priority rating of state-
ments within each cluster, which was graphically depicted by assigning layers to each cluster,
with more layers representing higher priority of the statements within that cluster. The software
labelled each cluster based on the labels previously assigned by participants, through word pat-
tern analysis. To obtain the concept map which best fit the data, both the minimum (5) and max-
imum (20) number of clusters able to describe the data were explored, i.e. the most general and
specific content analysis, respectively. These cut-off values are determined by the concept map-
ping software, which does not facilitate fewer than 5 or more than 20 clusters. Therefore, each
cluster rating map started with 20 clusters, after which a researcher (LR) evaluated the content of
each cluster and calculated the percentage of items within each cluster that corresponded to the
cluster label assigned by the software programme. Next, the number of clusters was reduced one
at a time until the data was represented by 5 clusters. At each step the percentage of statements
that corresponded to the category label assigned by the software was calculated (by LR). If the
thematic content of statements within one cluster was relatively homogeneous, but not ade-
quately represented by the label, a new label was manually assigned. The final cluster count per
country was based on the number of clusters that resulted in the highest percentage of statements
corresponding to each cluster label. Although the main cluster analysis was performed by one
researcher (LR), other researchers (DvdW, MB) were consulted in case of ambiguity.
Additionally, we explored whether type of profession influences participants’ perspectives,
distinguishing between clinicians and ‘other professionals’ (i.e. researchers and ‘other’) using
pattern match and Pearson correlation coefficients. Correlation coefficients were classified
according to the following guidelines: <0.5 low, 0.5–0.7 moderate, 0.7–0.9 high, and 0.9–1.0
very high positive correlation [20].
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The cluster rating maps representing the perspectives of participants from the Netherlands,
UK, and Sweden were compared to explore similarities and differences. Perspectives of the
Dutch, British, and Swedish participants were integrated by selecting the five themes with the
highest average priority rating across the three countries.
Results
Participant characteristics
A total of 48 participants were assigned to the brainstorm task: 19 Dutch professionals
(response rate: 68%), 16 British professionals (response rate 27%), and 13 Swedish profession-
als (response rate 17%). Ultimately, 44 participants completed all three tasks, with 4 (8.3%)
professionals dropping out at different stages due to the required time investment of around
90 minutes. Table 1 provides an overview of participant characteristics and sample sizes per
concept mapping task and participating country. Most of the participants in all three countries
were middle-aged females with a varied professional background and over 10 years of experi-
ence in the field.
Brainstorm: Generate statements
In response to the seeding statement, Dutch professionals generated a total of 124 unique state-
ments, British professionals 109, and Swedish professionals generated 75 unique statements.
S1 Table provides an overview of all generated clusters and statements, including the average
priority ratings, stratified by country.
Sort and rate statements
The Netherlands. The number of categories generated by Dutch participants ranged
from 4 to 24 (median = 9). Average statement ratings varied from 3.17 to 8.28, representing
the statement which was rated least important, i.e. ‘who has the time to participate in more fre-
quent screening?’, and most important, i.e. ‘a woman at high risk of developing breast cancer
Table 1. Characteristics of the participating professionals per country.
Task participants Netherlands United Kingdom Sweden
Total invited (n) 28 59 75
Participated brainstorm (n) 19 16 13
Unique statements generated (n) 124 109 75
Participated sorta (n) 17 14 11
Participated rateb (n) 17 15 12
Personal characteristics
Gender (% female) 84.2 75.0 66.7
Age (median in years, range) 54 [35–68] 48 [24–74] 45 [29–64]
Profession (n, %)
Researcher 7 (40) 3 (18) 5 (45)
Clinician 5 (27) 9 (53) 6 (54)
Otherc 5 (33) 5 (29) 1 (1)
Years of experience (median, range) 21 [8–37] 13 [2–48] 11 [5–38]
a participants that met the threshold criterion of having sorted at least 105 statements
b participants that met the threshold criterion of having rated at least one statement
c other professions included, e.g. dietician, manager screening unit, coordinator screening unit
https://doi.org/10.1371/journal.pone.0197772.t001
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wants a shorter screening interval’, respectively. The concept map of the Dutch professionals
generated a stress-value of 0.34, indicating sufficient fit. Fig 1 presents the cluster rating map
of Dutch professionals.
The cluster rating map providing the best fit contained the following nine categories: (1)
Anxiety/worry; (2) Proactive approach and stigma; (3) Defining and assessing risk; (4) Atti-
tude to risk; (5) Effect on screening outcomes; (6) Screening inequality; (7) Communicating
risk; (8) Freedom of choice; and (9) Effect on screening adherence. The category ‘Anxiety/
worry’ was considered most important with an average rating of 7.23, and includes statements
such as: ‘Increasing the screening frequency provides insecurity’, ‘Knowing you’re high risk
instils anxiety’, and ‘Having an increased risk due to non-modifiable risk factors will increase
anxiety and worry’. ‘Communicating risk’ was rated least relevant to women’s decision-mak-
ing process with an average rating of 5.22. This category contains statements such as: ‘Informa-
tion about preventative measures needs to be relayed by general practitioners’, ‘Information
about preventative measures needs to be relayed by clinicians’, and ‘There is no clear message
about preventative behaviours like diet and exercise’.
A comparison of the rating patterns of Dutch clinicians (n = 5) versus other Dutch profes-
sionals (n = 12) showed strong correlation (r = 0.78). Both groups prioritised ‘Proactive
approach’ and ‘Stigma’ in women’s decision-making process. However, clinicians valued the
importance of ‘Communication’ more than other professionals, rating it as the sixth most
important theme (out of nine), whereas other professionals assigned ‘Communication’ the
lowest rating.
United Kingdom. British participants generated between 5 and 26 categories (median = 8).
Average statement ratings varied from 4.00 (statement: ‘Is personalised risk-based breast can-
cer screening and primary prevention performed in other countries’) to 9.13 (statement: ‘This
may help my children or other relatives; if my risk is high, theirs could be too’). The overall fit
of the British concept map was sufficient with a stress-value of 0.29. Fig 2 presents the cluster
rating map of British professionals.
The cluster rating map which best fit the data contained the following seven categories: (1)
Proactive approach; (2) Anxiety/worry; (3) Organisation of risk assessment and feedback; (4)
Lack of knowledge; (5) Psychological impact of knowing risk; (6) Concerns about accuracy;
and (7) Acceptance of risk without intervention. British professionals regarded the category
‘Proactive approach’ as most important to a woman’s decision-making process of participating
Fig 1. Cluster rating map the Netherlandsa. aEach cluster rating map displays clusters containing statements (the
dots) that are similar in thematic content. The layer(s) of each cluster represents the average priority ratings of the
statements within that cluster, more layers signify higher priority. The legend provides an indication of the average
priority ratings that the statements within each cluster received.
https://doi.org/10.1371/journal.pone.0197772.g001
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in personalised screening and prevention (average rating = 7.76). This cluster includes state-
ments such as: ‘I can take control of some of my own risk factors and take steps to reduce
them’ and ‘I want to do everything I can to avoid breast cancer’. ‘Acceptance of risk without
intervention’ was considered least relevant (average rating = 6.53). Statements clustered within
this theme, include: ‘I can’t change it anyway, so why find out what the risk is?’, ‘I feel it’s fate
and I don’t want to know my risk’, ‘I don’t feel any extra benefit from knowing my risk; ‘I
won’t change my behaviour so what is the point’, and ‘I just want to live a normal life’.
A comparison of the rating patterns of British clinicians (n = 9) versus other British profes-
sionals (n = 6) showed a low correlation (r = 0.46). Although both groups prioritised ‘Proactive
approach’ and ‘Anxiety/worry’, there were large discrepancies in the prioritisation of the other
themes. Clinicians prioritised ‘Lack of knowledge’ and ‘Concerns about accuracy’, whereas
other professionals prioritised ‘Organisation of risk assessment and feedback’ and ‘Psychologi-
cal impact of knowing risk’. Conversely, ‘Concerns about accuracy’ was considered the least
important theme by the other professionals.
Sweden. Swedish participants generated between 3 and 15 categories (median = 11). Aver-
age statement ratings varied from 3.90 (statement: ‘why am I paying for high risk women to
attend screening more frequently?’) to 9.00 (statement: ‘I want to be informed of both the ben-
efits and the risks of personalised screening and prevention’). The overall fit of the concept
map generated by the data of the Swedish participants was sufficient (stress-value = 0.29). Fig
3 presents the cluster rating map of the Swedish professionals.
The cluster rating map which provided the best fit contained eight categories: (1) Reassur-
ance; (2) Anxiety/worry; (3) Fatalistic thinking; (4) Lack of knowledge; (5) Hereditary aspects;
(6) Inequality in screening; (7) Confidentiality; and (8) Lifestyle challenges. The category with
the highest average priority rating was ‘Reassurance’ (7.45), which includes statements such as:
‘I experience an increased sense of safety because I know my risk’ and ‘I feel reassured because
additional methods will be used when mammography is not enough’. The categories ‘Confi-
dentiality’ and ‘Lifestyle challenges’ were considered least relevant to women’s decision-mak-
ing process with average rating scores of 5.75 and 5.76, respectively. ‘Confidentiality’ contains
statements such as: ‘Will I lose my job if my employer knows I’m at high risk of developing
breast cancer?’, ‘Will my employer get access to my risk estimate?’, and ‘Will my private health
insurance premium increase?’. Examples of statements in ‘Guilt about lifestyle’ are: ‘I feel
ashamed since I can’t get rid of my excess weight, which increases my risk of developing breast
cancer’ and ‘I find it too difficult to change my lifestyle’.
Fig 2. Cluster rating map United Kingdoma. aEach cluster rating map displays clusters containing statements (the
dots) that are similar in thematic content. The layer(s) of each cluster represents the average priority ratings of the
statements within that cluster, more layers signify higher priority. The legend provides an indication of the average
priority ratings that the statements within each cluster received.
https://doi.org/10.1371/journal.pone.0197772.g002
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A comparison of the rating patterns of Swedish clinicians (n = 6) versus other Swedish pro-
fessionals (n = 6) showed moderate correlation (r = 0.60). Both groups prioritised ‘Reassur-
ance’ in women’s decision-making. Clinicians further prioritised ‘Lack of knowledge’ and ‘
Hereditary aspects’, whereas other professionals prioritised ‘Fatalistic thinking’ and ‘Anxiety/
worry’. Clinicians considered the theme of ‘Fatalistic thinking’ to be relatively unimportant in
the decision-making process, rating it sixth out of seven, before ‘Lifestyle challenges’. Other
professionals considered ‘Confidentiality’ the least important theme.
Integration and cultural variation
Comparing the cluster rating maps of the three countries on thematic level, it transpires that
the following five themes are prioritised by professionals: (1) Anxiety/worry; (2) Proactive
approach; (3) Reassurance; (4) Lack of knowledge; and (5) Organisation of risk assessment
and feedback.
Moreover, the themes show several differences in professionals’ perspectives. Both Dutch
and British professionals considered voluntary participation relevant to women’s decision-
making. Swedish professionals, however, did not prioritise this topic. Swedish professionals
emphasised the potential impact of the new screening and prevention paradigm on family rela-
tions and the challenges involved in adopting lifestyle changes. Together with British profes-
sionals they also prioritised potential psychological consequences of risk feedback other than
anxiety and worry, and emphasised women’s lack of knowledge. Furthermore, Dutch and
Swedish professionals mentioned the heterogeneous nature of the new programme. Conclu-
sively, only Dutch professionals identified communication, potential effects on screening out-
comes and adherence, and stigma (i.e. personal responsibility for health) as themes which
could influence decision-making.
Discussion
The present study explored professionals’ perceptions of women’s decision-making regarding
participation in personalised breast cancer screening and prevention. Distinct differences in
perceptions were visible across professionals from the Netherlands, UK, and Sweden when
evaluating the themes that were generated. However, these differences appeared less
Fig 3. Cluster rating map Swedena. aEach cluster rating map displays clusters containing statements (the dots) that
are similar in thematic content. The layer(s) of each cluster represents the average priority ratings of the statements
within that cluster, more layers signify higher priority. The legend provides an indication of the average priority ratings
that the statements within each cluster received.
https://doi.org/10.1371/journal.pone.0197772.g003
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pronounced after evaluation of the generated statements on item-level, showing similar state-
ments that were grouped and labelled differently depending on the country (S1 Table).
The central theme which was mentioned consistently by professionals of all three countries
was ‘Anxiety/worry’. Professionals perceived the screening and prevention programme to
induce anxiety about personal breast cancer risk, (late) detection of breast cancer, confronta-
tion with an unhealthy lifestyle, chemoprevention, and the potential impact on relatives. This
is in line with views expressed by women in previous research who described a concern for the
potential impact of breast cancer risk information on their lives and their ability to manage
subsequent decisions regarding screening and prevention [15]. The term ‘chemoprevention’
for risk-reducing medication in particular has been shown to elicit strong reactions through its
perceived association with breast cancer and women’s reluctance to disrupt their current state
of health, fearing debilitating side effects [16,21]. Additionally, although the assigned category
labels may not automatically suggest this, professionals from all three countries generated
statements about other potential psychological consequences which correspond to concerns
mentioned by women in previous studies, e.g. false reassurance and fatalistic, obsessive think-
ing [14,16,21]. However, when categorising the statements and assigning category labels, pro-
fessionals from each country used different words to describe these themes, which is reflected
in the labels assigned by the software.
Besides ‘Anxiety/worry’ four other themes received high average priority ratings from pro-
fessionals, i.e. ‘Proactive approach’, ‘Reassurance’, ‘Lack of knowledge’, and ‘Organisation of
risk assessment and feedback’. The first three themes are in concordance with women’s per-
ceptions of personalised breast cancer screening and prevention. Women have identified a
proactive approach, perceived reassurance and knowledge as incentives to participate in the
programme. They indicated that being proactive provides a sense of calm and perceived con-
trol [22–24]. Women related reassurance to the intensified screening and prevention pro-
gramme that would be provided if they were above average risk [25]. Conversely, receiving a
below average risk result provided no perceived reassurance [13,14]. Increased knowledge
facilitated women’s acceptability of personalised screening and prevention, particularly of
risk-reducing medication [8,17,25]. These similarities between professionals’ and women’s
perceptions of factors that may influence participation will facilitate a shared decision-making
process.
The priority assigned to the theme ‘Organisation of risk assessment and feedback’ appears
to reflect professionals’ personal perspectives, since this topic was not previously mentioned by
women. Statements in this category mainly relate to potential provider(s) of risk information
and counselling, perceived accuracy of risk, and the pathway of care a woman will be assigned
to based on her risk. These topics are also reflected in four other themes, i.e. ‘Defining and
assessing risk’, ‘Effect on screening outcomes’, ‘Effect on screening adherence’, and ‘Concerns
about accuracy’. Noticeably, these themes were mentioned by either Dutch or British profes-
sionals, but not by Swedish professionals. Participating professionals from NL and UK
approached the acceptability of the programme with some scepticism, suggesting that women
will question their personal risk information and their assigned pathway of care (e.g. screening
frequency or biomedical prevention). Additionally, Dutch and British professionals fear more
overdiagnosis and overtreatment, and expect an increase in opportunistic screening, particu-
larly from women at below average risk. This perception is not supported by Evans and col-
leagues who relayed personal breast cancer risk information to women participating in the UK
screening programme [26]. Women who were identified as below average risk were less likely
to attend the following mammogram than women who were found to be at above average risk
[26]. This may suggest that women at below average risk supported the idea of decreasing the
screening frequency. Alternatively, it may also indicate that women experience a sense of false
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reassurance, considering the relatively wide screening interval in the UK of three years. It is
important to address the concerns expressed by Dutch and British professionals before imple-
mentation, since previous research has shown that professionals who question the effectiveness
of risk-based screening and prevention are less likely to breach the topic with eligible women
[6,9,11]. Future research should further explore the acceptability of risk-based breast cancer
screening and prevention from the perspective of eligible women, focusing on women’s views
on breast cancer risk assessment, communication, and subsequent pathways of care (including
potential opportunistic screening or lower screening intent).
Professionals appeared not to reference or prioritise risk communication; only Dutch profes-
sionals labelled a category accordingly. However, evaluation of the individual statements gener-
ated by participants of each country shows that all professionals explored some aspects of risk
communication, e.g. provider or type of information. Insights in the topics that need to be dis-
cussed with eligible women is provided by a theme generated by both British and Swedish pro-
fessionals labelled ‘Lack of knowledge’. This theme contains statements such as: ‘Does high risk
mean I will develop breast cancer?’, ‘What alternative surveillance do I get if I am no longer
offered screening?’, ‘How are my risk factors assessed?’, and ‘Are there other ways to reduce my
risk of breast cancer?’. Professionals have previously indicated that risk information should be
elaborate and presented in different formats [11]. Furthermore, they pointed out a need for addi-
tional training in risk communication to facilitate women’s understanding [27,28]. Suggested
practice in risk communication encourages professionals to, e.g. avoid relative risks, encourage
women to reflect on screening and preventive preferences from different perspectives, and to
recognise that a woman’s decision may not reflect the professional’s preference [29].
Strengths and limitations
A major strength of the present study is the participation of a wide variety of professionals
from three European countries. This enabled cross-cultural comparisons in professionals’
perceptions of women’s decision-making regarding personalised breast cancer screening and
prevention. However, due to the relatively small sample sizes per country it is difficult to con-
clusively ascertain whether the demonstrated differences are due to cultural variation or
another reason, e.g. professional background. The British sample contained a relatively high
proportion of clinicians compared with the Dutch and Swedish samples. This may have
affected the integrated professional perspective, because clinicians generally have more contact
with women than researchers, and may therefore have a clearer understanding of women’s
perceptions.
The data analysis was performed by one researcher, however, methods were objectified by
systematically assessing the thematic content of each cluster for the most general to the most
specific content analysis as elaborated on in the methods section.
Concept mapping software enabled a time efficient, systematic approach to the analysis of
qualitative data minimising individual interpretation bias, by analysing participants’ sorts and
mean priority ratings. Consequently, the software relies heavily on the participant data, which
will vary in quality. This can lead to suboptimal results, particularly in the cluster analysis,
where participants’ categorisation of statements is averaged. It is conceivable that participants
who generated relatively few categories negatively impact the analysis, by grouping statements
together which are reasonably dissimilar in content. This has resulted in some categories con-
taining statements that do not optimally match the assigned label (S1 Table). However, overall
we believe the concept maps provide a relevant overview of themes that are potentially associ-
ated with women’s decision-making process regarding personalised breast cancer screening
and prevention.
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Conclusion
The perspectives of Dutch, British, and Swedish professionals of women’s decision-making
regarding personalised breast cancer screening and prevention generally appear in line with
women’s own views of acceptability, which will facilitate shared decision-making. However,
concerns regarding potential consequences of this new programme for screening outcomes
and organisation need to be addressed, since this may affect how professionals communicate
the programme to eligible women.
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